Annual Accounts Payable
$358.00 K
-$1.49 M-80.64%
June 30, 2024
Summary
- As of February 8, 2025, IBIO annual accounts payable is $358.00 thousand, with the most recent change of -$1.49 million (-80.64%) on June 30, 2024.
- During the last 3 years, IBIO annual accounts payable has fallen by -$1.90 million (-84.12%).
- IBIO annual accounts payable is now -91.60% below its all-time high of $4.26 million, reached on June 30, 2022.
Performance
IBIO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$855.00 K
+$497.00 K+138.83%
September 30, 2024
Summary
- As of February 8, 2025, IBIO quarterly accounts payable is $855.00 thousand, with the most recent change of +$497.00 thousand (+138.83%) on September 30, 2024.
- Over the past year, IBIO quarterly accounts payable has increased by +$497.00 thousand (+138.83%).
- IBIO quarterly accounts payable is now -83.80% below its all-time high of $5.28 million, reached on March 31, 2022.
Performance
IBIO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
IBIO Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -80.6% | +138.8% |
3 y3 years | -84.1% | -57.5% |
5 y5 years | -64.2% | -57.5% |
IBIO Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -91.6% | at low | -83.8% | +138.8% |
5 y | 5-year | -91.6% | at low | -83.8% | +138.8% |
alltime | all time | -91.6% | +218.8% | -83.8% | +661.4% |
IBio Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $855.00 K(+138.8%) |
Jun 2024 | $358.00 K(-80.6%) | $358.00 K(-70.8%) |
Mar 2024 | - | $1.23 M(-33.9%) |
Dec 2023 | - | $1.86 M(-2.7%) |
Sep 2023 | - | $1.91 M(+3.4%) |
Jun 2023 | $1.85 M(-56.6%) | $1.85 M(-8.1%) |
Mar 2023 | - | $2.01 M(-49.7%) |
Dec 2022 | - | $4.00 M(-16.7%) |
Sep 2022 | - | $4.81 M(+12.7%) |
Jun 2022 | $4.26 M(+89.2%) | $4.26 M(-19.2%) |
Mar 2022 | - | $5.28 M(+92.7%) |
Dec 2021 | - | $2.74 M(+19.5%) |
Sep 2021 | - | $2.29 M(+1.7%) |
Jun 2021 | $2.25 M(+28.1%) | $2.25 M(+38.2%) |
Mar 2021 | - | $1.63 M(-32.3%) |
Dec 2020 | - | $2.41 M(+50.4%) |
Sep 2020 | - | $1.60 M(-8.9%) |
Jun 2020 | $1.76 M(+75.7%) | $1.76 M(+221.6%) |
Mar 2020 | - | $547.00 K(+23.8%) |
Dec 2019 | - | $442.00 K(-33.1%) |
Sep 2019 | - | $661.00 K(-34.0%) |
Jun 2019 | $1.00 M(+26.7%) | $1.00 M(+38.6%) |
Mar 2019 | - | $722.00 K(+9.1%) |
Dec 2018 | - | $662.00 K(-4.3%) |
Sep 2018 | - | $692.00 K(-12.4%) |
Jun 2018 | $790.00 K(+5.5%) | $790.00 K(-15.9%) |
Mar 2018 | - | $939.00 K(+34.0%) |
Dec 2017 | - | $701.00 K(+17.6%) |
Sep 2017 | - | $596.00 K(-20.4%) |
Jun 2017 | $749.00 K(-36.4%) | $749.00 K(-46.2%) |
Mar 2017 | - | $1.39 M(+90.3%) |
Dec 2016 | - | $731.00 K(-25.3%) |
Sep 2016 | - | $979.00 K(-16.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2016 | $1.18 M(+6.6%) | $1.18 M(-24.1%) |
Mar 2016 | - | $1.55 M(+16.3%) |
Dec 2015 | - | $1.33 M(+5.0%) |
Sep 2015 | - | $1.27 M(+15.1%) |
Jun 2015 | $1.10 M(+271.7%) | $1.10 M(+35.5%) |
Mar 2015 | - | $815.00 K(-17.2%) |
Dec 2014 | - | $984.00 K(+90.7%) |
Sep 2014 | - | $516.00 K(+73.7%) |
Jun 2014 | $297.00 K(-87.6%) | $297.00 K(-73.4%) |
Mar 2014 | - | $1.12 M(-10.2%) |
Dec 2013 | - | $1.25 M(-5.2%) |
Sep 2013 | - | $1.31 M(-45.3%) |
Jun 2013 | $2.40 M(-15.6%) | $2.40 M(-0.6%) |
Mar 2013 | - | $2.42 M(-10.9%) |
Dec 2012 | - | $2.71 M(+12.1%) |
Sep 2012 | - | $2.42 M(-15.0%) |
Jun 2012 | $2.85 M(-1.7%) | $2.85 M(+30.4%) |
Mar 2012 | - | $2.18 M(-46.0%) |
Dec 2011 | - | $4.04 M(+35.6%) |
Sep 2011 | - | $2.98 M(+2.9%) |
Jun 2011 | $2.90 M(+44.3%) | $2.90 M(+162.8%) |
Mar 2011 | - | $1.10 M(-44.1%) |
Dec 2010 | - | $1.97 M(-8.8%) |
Sep 2010 | - | $2.16 M(+7.6%) |
Jun 2010 | $2.01 M(+1687.4%) | $2.01 M(+85.9%) |
Mar 2010 | - | $1.08 M(-45.1%) |
Dec 2009 | - | $1.97 M(+1649.8%) |
Jun 2009 | $112.30 K(-77.8%) | $112.30 K(-25.2%) |
Mar 2009 | - | $150.20 K(-59.7%) |
Dec 2008 | - | $373.00 K(+152.4%) |
Sep 2008 | - | $147.80 K(-70.8%) |
Jun 2008 | $505.90 K(+43.1%) | $505.90 K |
Jun 2007 | $353.50 K | - |
FAQ
- What is iBio annual accounts payable?
- What is the all time high annual accounts payable for iBio?
- What is iBio annual accounts payable year-on-year change?
- What is iBio quarterly accounts payable?
- What is the all time high quarterly accounts payable for iBio?
- What is iBio quarterly accounts payable year-on-year change?
What is iBio annual accounts payable?
The current annual accounts payable of IBIO is $358.00 K
What is the all time high annual accounts payable for iBio?
iBio all-time high annual accounts payable is $4.26 M
What is iBio annual accounts payable year-on-year change?
Over the past year, IBIO annual accounts payable has changed by -$1.49 M (-80.64%)
What is iBio quarterly accounts payable?
The current quarterly accounts payable of IBIO is $855.00 K
What is the all time high quarterly accounts payable for iBio?
iBio all-time high quarterly accounts payable is $5.28 M
What is iBio quarterly accounts payable year-on-year change?
Over the past year, IBIO quarterly accounts payable has changed by +$497.00 K (+138.83%)